Beijing Winsunny Pharmaceutical CO.LTD (601089) — Financial Flexibility Index

Latest as of December 2024: 0.86x

Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Financial Flexibility Index of 0.86x as of December 2024. Free cash flow of CN¥1.08 Billion (operating CF CN¥690.75 Million minus capex CN¥391.52 Million) represents 1% of total liabilities (CN¥1.26 Billion). Check Beijing Winsunny Pharmaceutical CO.LTD total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Financial Flexibility Index

0.86x
Free Cash Flow / Total Liabilities

Free Cash Flow

CN¥1.08 Billion
Operating CF − Capex

Total Liabilities

CN¥1.26 Billion
CNY

Capital Expenditures

CN¥391.52 Million
CNY

Beijing Winsunny Pharmaceutical CO.LTD Financial Flexibility Index (2020–2024)

Historical Financial Flexibility Index trend for Beijing Winsunny Pharmaceutical CO.LTD across 5 annual periods. For the full cash flow conversion analysis, see 601089 operating cash flow.

Annual Financial Flexibility Index for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)

Year-by-year free cash flow to debt coverage for Beijing Winsunny Pharmaceutical CO.LTD. Explore Beijing Winsunny Pharmaceutical CO.LTD cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (CNY) Operating CF Total Liabilities YoY Change
2024 0.86x CN¥1.08 Billion CN¥690.75 Million CN¥1.26 Billion ▼ -0.2%
2023 0.86x CN¥921.98 Million CN¥555.90 Million CN¥1.07 Billion ▲ +23.7%
2022 0.70x CN¥795.17 Million CN¥659.76 Million CN¥1.14 Billion ▼ -9.5%
2021 0.77x CN¥721.00 Million CN¥528.02 Million CN¥937.86 Million ▼ -1.9%
2020 0.78x CN¥555.62 Million CN¥386.65 Million CN¥709.01 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities